Differential Effects of Novel Dopamine Reuptake Inhibitors on Interference With Long-Term Social Memory in Mice.

aggression social interaction cognitive enhancement dopamine transport inhibitor long-term memory retroactive interference social recognition memory

Journal

Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952

Informations de publication

Date de publication:
2019
Historique:
received: 28 08 2018
accepted: 13 03 2019
entrez: 30 4 2019
pubmed: 30 4 2019
medline: 30 4 2019
Statut: epublish

Résumé

In the laboratory, long-term social recognition memory (SRM) in mice is highly susceptible to proactive and retroactive interference. Here, we investigate the ability of novel designed dopamine (DA) re-uptake inhibitors (

Identifiants

pubmed: 31031603
doi: 10.3389/fnbeh.2019.00063
pmc: PMC6470289
doi:

Types de publication

Journal Article

Langues

eng

Pagination

63

Subventions

Organisme : Austrian Science Fund FWF
ID : I 2433
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 28146
Pays : Austria

Références

Learn Mem. 2005 Jul-Aug;12(4):407-13
pubmed: 16077019
Brain Res Bull. 1991 Jan;26(1):23-7
pubmed: 1673081
Int J Neuropsychopharmacol. 2007 Jun;10(3):383-99
pubmed: 16925890
Trends Neurosci. 1991 Jul;14(7):299-302
pubmed: 1719677
Behav Brain Res. 2008 Jan 25;186(2):191-6
pubmed: 17875328
Neurobiol Learn Mem. 2009 Jan;91(1):58-65
pubmed: 18812226
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2652-7
pubmed: 20133798
Neurobiol Learn Mem. 2010 Nov;94(4):568-75
pubmed: 20888419
Nat Protoc. 2011 Jul 14;6(8):1152-62
pubmed: 21799485
Biol Psychiatry. 2012 Sep 1;72(5):405-13
pubmed: 22537794
Nature. 2014 Apr 3;508(7494):88-92
pubmed: 24572357
Physiol Behav. 2015 May 1;143:10-4
pubmed: 25703187
Front Neurosci. 2015 Apr 29;9:152
pubmed: 25972782
Eur Neuropsychopharmacol. 2015 Nov;25(11):1865-81
pubmed: 26381811
Curr Top Behav Neurosci. 2017;30:25-45
pubmed: 26643999
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4914-9
pubmed: 27482097
Eur J Neurosci. 2017 Jan;45(1):167-174
pubmed: 27545285
J Neurosci. 2017 Apr 12;37(15):4103-4116
pubmed: 28292834
Behav Brain Res. 2017 Sep 15;334:129-134
pubmed: 28760699
J Med Chem. 2017 Nov 22;60(22):9330-9348
pubmed: 29091428
Front Behav Neurosci. 2017 Nov 27;11:222
pubmed: 29230168
J Neurosci. 2018 Jan 31;38(5):1218-1231
pubmed: 29279308
Behav Brain Res. 2018 May 2;343:83-94
pubmed: 29410048
ACS Chem Neurosci. 2019 Apr 17;10(4):2012-2021
pubmed: 30645944
Psychopharmacology (Berl). 1987;91(3):363-8
pubmed: 3104959
J Neurochem. 1996 Feb;66(2):559-68
pubmed: 8592125
Prog Neurobiol. 1998 Feb;54(3):289-311
pubmed: 9481800

Auteurs

Judith Camats-Perna (J)

AG Neuroendokrinologie und Verhalten, Institut für Biochemie und Zellbiologie, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany.

Predrag Kalaba (P)

Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.

Karl Ebner (K)

Center for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology and Toxicology, Institute of Pharmacy, Leopold Franzens University Innsbruck, Innsbruck, Austria.

Simone B Sartori (SB)

Center for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology and Toxicology, Institute of Pharmacy, Leopold Franzens University Innsbruck, Innsbruck, Austria.

Harish Vuyyuru (H)

Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.

Nilima Y Aher (NY)

Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.

Vladimir Dragačević (V)

Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.

Nicolas Singewald (N)

Center for Molecular Biosciences Innsbruck (CMBI), Department of Pharmacology and Toxicology, Institute of Pharmacy, Leopold Franzens University Innsbruck, Innsbruck, Austria.

Mario Engelmann (M)

AG Neuroendokrinologie und Verhalten, Institut für Biochemie und Zellbiologie, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany.
Center for Behavioral Brain Sciences, Magdeburg, Germany.

Gert Lubec (G)

Department of Neuroproteomics, Paracelsus Medical University, Salzburg, Austria.

Classifications MeSH